Cervical Cancer Screening Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Cervical Cancer Screening Market: By Test Type (Pap Smear Tests, HPV Tests, LBC Tests, Others), and Geography  

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Cervical Cancer Screening Market Size is estimated to be valued at USD 8,152.6 Million in 2021 and is expanded to grow at a significant CAGR of 5.4% over 2022-2028. An increase in the prevalence of cervical cancer due to the surge in the global female population is a considerable factor surge the growth of the cervical cancer screening market over the forecast years. Moreover, raising awareness about the cancer diseases among the people in developed countries, the surge in demand for early-stage disease diagnosis, and favorable reimbursement policies are enhancing the market’s revenue. In addition, the increase in consumption of tobacco and alcohol among the female population, the surge in prevalence of HPV infection, increase in the incidence of unsafe sex also boost the market over the forecast timeframe. Development of newer tests to diagnose cervical cancer in a more efficient way and expansion of the business into low-income markets and high prevalence of cervical cancer countries creates some opportunities for marketers. In the cervical cancer screening market, the pap smear tests segment is estimated to lead the global cervical cancer screening market in 2022, in terms of value and volume, owing to increased government funding and insurance coverage.

Recent Market Developments:

In November 2020, Hologic, Inc. announced that its new Genius™ Digital Diagnostics System is CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Cervical Cancer Screening Market

MARKET SUMMARY
-
5.4% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.4%
  • Largest Market– North America
  • Fastest Growing Market– North America

Cervical Cancer Screening Market

  • The cervical cancer screening market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The cervical cancer screening market is segmented based on test type and geography.
Key Players
  • Abbott.
  • Hologic, Inc.
  • QIAGEN
  • Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated.
Cervical Cancer Screening Market

Dynamics

The global cervical cancer screening market is mainly driven by the increased prevalence of cervical cancer cases and fundraising for cervical cancer screening programs. Changes in the screening criteria, screening rates, lack of awareness about cervical cancer, and adoption of alternate testing procedures will hinder the market growth.


North-America Got Significant Share

Cervical Cancer Screening Market

In 2021, the North American cervical cancer screening market had the highest market share at 42.7 percent. The aging female population, the high incidence of cervical cancer, and rising HPV infection rates drive growth in the North American market. In addition, Europe will be the second-largest shareholder owing to the favorable health reimbursement and rapid adoption of advanced cervical cancer screening procedures.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cervical Cancer Screening Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The cervical cancer screening market is projected to expand at a CAGR of 5.4% during the forecast period.

Abbott., Hologic, Inc., QIAGEN, Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated.

North America and Asia-Pacific is the fastest-growing cervical cancer screening market


Report

Company Profile

  • Hologic, Inc.
  • Abbott,
  • QIAGEN
  • Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated.
  • Becton, Dickinson, and Company
  • Cooper Surgical Inc.,
  • Arbor Vita Corporation,

Description

Cervical Cancer Screening Market Size is estimated to be valued at USD 8,152.6 Million in 2021 and is expanded to grow at a significant CAGR of 5.4% over 2022-2028. An increase in the prevalence of cervical cancer due to the surge in the global female population is a considerable factor surge the growth of the cervical cancer screening market over the forecast years. Moreover, raising awareness about the cancer diseases among the people in developed countries, the surge in demand for early-stage disease diagnosis, and favorable reimbursement policies are enhancing the market’s revenue. In addition, the increase in consumption of tobacco and alcohol among the female population, the surge in prevalence of HPV infection, increase in the incidence of unsafe sex also boost the market over the forecast timeframe. Development of newer tests to diagnose cervical cancer in a more efficient way and expansion of the business into low-income markets and high prevalence of cervical cancer countries creates some opportunities for marketers. In the cervical cancer screening market, the pap smear tests segment is estimated to lead the global cervical cancer screening market in 2022, in terms of value and volume, owing to increased government funding and insurance coverage.

Recent Market Developments:

In November 2020, Hologic, Inc. announced that its new Genius™ Digital Diagnostics System is CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Reviews

There are no reviews yet.

Be the first to review “Cervical Cancer Screening Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX